Deciphera Pharmaceuticals, Inc.

Release Summary

Deciphera Preclinical Data Presented at 2018 AACR Annual Meeting Confirms Broad Spectrum of Potent Mutational inhibition with DCC-2618 in GIST

Deciphera Pharmaceuticals, Inc.